About Retatrutide
Retatrutide is studied as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors, and is used in laboratory research focused on complex metabolic signaling. It is supplied as a lyophilized powder for investigations into receptor pharmacology, energy metabolism pathways, and glucose regulation mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.
Recent research on Retatrutide: Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.
Read Full Study on PubMedNext-generation incretin therapeutics for polyendocrine metabolic ovarian syndrome: navigating current pipeline and clinical considerations.
Recent research on Retatrutide: Next-generation incretin therapeutics for polyendocrine metabolic ovarian syndrome: navigating current pipeline and clinical considerations.
Read Full Study on PubMedAdditional Studies
Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity.
Recent research on Retatrutide: Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity.
Read on PubMedGlucose-dependent insulinotropic polypeptide (GIP) signaling in visceral and subcutaneous adipose tissue: implications for obesity and metabolic disease-a narrative review with a structured literature search.
Recent research on Retatrutide: Glucose-dependent insulinotropic polypeptide (GIP) signaling in visceral and subcutaneous adipose tissue: implications for obesity and metabolic disease-a narrative review with a structured literature
Read on PubMedRetatrutide Once Weekly for Treatment of Obstructive Sleep Apnea.
Recent research on Retatrutide: Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea.
Read on PubMedRetatrutide treatment in streptozotocin-induced diabetic rats: renal inflammatory cytokines, HIF‑1α expression, and histopathological injury profile.
Recent research on Retatrutide: Retatrutide treatment in streptozotocin-induced diabetic rats: renal inflammatory cytokines, HIF‑1α expression, and histopathological injury profile.
Read on PubMedGLP-1 receptor agonists and hair loss: adverse effect, epiphenomenon, or therapeutic paradox?
Recent research on Retatrutide: GLP-1 receptor agonists and hair loss: adverse effect, epiphenomenon, or therapeutic paradox?
Read on PubMedRetatrutide in adults with obesity and type 2 diabetes: what have we learned from TRIUMPH-2?
Recent research on Retatrutide: Retatrutide in adults with obesity and type 2 diabetes: what have we learned from TRIUMPH-2?
Read on PubMedRelated Research
Purchase Retatrutide from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.
